The understanding that hemoglobin A1c (HbA1c) represents the average blood glucose level of patients over the previous 120 days underlies the current management of diabetes. Even in making such a statement, we speak of “average blood glucose” as though “blood glucose” were itself a simple idea. When we consider all the blood glucose forms—arterial versus venous versus capillary, whole blood versus serum versus fluoride-preserved plasma, fasting versus nonfasting—we can start to see that this is not a simple issue.
Nevertheless, it seems as though HbA1c correlates to any single glucose measurement. Having more than one measurement and taking those measurements in the preceding month improves the correlation further. In particular, by having glucose measurements that reflect both the relatively lower overnight glucose levels and measurements that reflect the postprandial peaks improves not only our ability to manage diabetes patients, but also our understanding of how HbA1c levels are determined. Modern continuous glucose monitoring (CGM) devices may take thousands of glucose results over a week. Several studies have shown that CGM glucose averages account for the vast proportion of the variation of HbA1c.
The ability to relate HbA1c to average glucose may become a popular method for reporting HbA1c, eliminating current concerns regarding differences in HbA1c standardization. Hemoglobin A1c expressed as an average glucose may be more understandable to patients and improve not only their understanding, but also their ability to improve their diabetes management.
CastilhoEMGlassMLMançoJC. The effects of 2,3-diphosphoglycerate, adenosine triphosphate, and glycosylated hemoglobin on the hemoglobin-oxygen affinity of diabetic patients. Braz J Med Biol Res.2003;36 (6): 731–7.
2.
NathanDMSingerDEHurxthalKGoodsonJD. The clinical information value of the glycosylated hemoglobin assay. N Engl J Med.1984;310 (6): 341–6.
3.
TaharaYShimaK. The response of GHb to stepwise plasma glucose change over time in diabetic patients. Diabetes Care.1993;16 (9): 1313–4.
4.
VirtueMAFurneJKNuttallFQLevittMD. Relationship between GHb concentration and erythrocyte survival determined from breath carbon monoxide concentration. Diabetes Care.2004;27 (4): 931–5.
5.
CohenRMFrancoRSKheraPKSmithEPLindsellCJCiraoloPJPalascakMBJoinerCH. Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood.2008;112 (10): 4284–91.
6.
GambinoR. Glucose: a simple molecule that is not simple to quantify. Clin Chem.2007;53 (12): 2040–1.
7.
HagvikJ. Glucose measurement: time for a gold standard. J Diabetes Sci Technol.2007;1 (2): 169–72.
8.
HunsleyBRyanW. Whole blood glucose standard is key to accurate insulin dosages. J Diabetes Sci Technol.2007;1 (2): 173–7.
9.
RaoLVJakubiakFSidwellJSWinkelmanJWSnyderML. Accuracy evaluation of a new glucometer with automated hematocrit measurement and correction. Clin Chim Acta.2005;356 (1–2): 178–83.
10.
BurnettRWD'OrazioPFogh-AndersenNKuwaKKülpmannWRLarssonLLewnstamAMaasAHMagerGSpichiger-KellerU, Scientific Division, Working Group on Selective Electrodes. IFCC recommendation on reporting results for blood glucose. Clin Chim Acta.2001;307 (1–2): 205–9.
11.
D'OrazioPBurnettRWFogh-AndersenNJacobsEKuwaKKülpmannWRLarssonLLewenstamAMaasAHMagerGNaskalskiJWOkoroduduAO, International Federation of Clinical Chemistry Scientific Division Working Group on Selective Electrodes and Point of Care Testing. Approved IFCC recommendation on reporting results for blood glucose (abbreviated). Clin Chem.2005;51 (9): 1573–6.
12.
D'OrazioPBurnettRWFogh-AndersenNJacobsEKuwaKKülpmannWRLarssonLLewenstamAMaasAHMagerGNaskalskiJWOkoroduduAO, IFCC-SD-WG-SEPOCT. Approved IFCC recommendation on reporting results for blood glucose: International Federation of Clinical Chemistry and Laboratory Medicine Scientific Division, Working Group on Selective Electrodes and Point-of-Care Testing (IFCC-SD-WG-SEPOCT). Clin Chem Lab Med.2006;44 (12): 1486–90.
13.
ColagiuriSSandbaekACarstensenBChristensenJGlumerCLauritzenTBorch-JohnsenK. Comparability of venous and capillary glucose measurements in blood. Diabet Med.2003;20 (11): 953–6.
14.
StorkADKempermanHErkelensDWVenemanTF. Comparison of the accuracy of the HemoCue glucose analyzer with the Yellow Springs Instrument glucose oxidase analyzer, particularly in hypoglycemia. Eur J Endocrinol.2005;153 (2): 275–81.
15.
WahabPJRijnsburgerAWOolbekkinkMHeineRJ. Venous versus arterialised venous blood for assessment of blood glucose levels during glucose clamping: comparison in healthy men. Horm Metab Res.1992;24 (12): 576–9.
16.
LiuDMobergEKollindMLinsPEAdamsonUMacdonaldIA. Arterial, arterialized venous, venous and capillary blood glucose measurements in normal man during hyperinsulinaemic euglycaemia and hypoglycaemia. Diabetologia.1992;35 (3): 287–90.
17.
NayakPPMorrisKLangHLakerSStickleyJDaviesPBarrettTGaoFGoughSNarendranP. Lack of agreement between arterial and central venous blood glucose measurement in critically ill children. Intensive Care Med.2008. [Epub ahead of print].
18.
LacaraTDomagtoyCLickliterDQuattrocchiKSnipesLKuszajJKuszajJPrasnikarM. Comparison of point-of-care and laboratory glucose analysis in critically ill patients. Am J Crit Care.2007;16 (4): 336–46.
19.
KanjiSBuffieJHuttonBBuntingPSSinghAMcDonaldKFergussonDMcIntyreLAHebertPC. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med.2005;33 (12): 2778–85.
20.
Slater-MacLeanLCembrowskiGChinDShalapayCBinetteTHegadorenKNewburn-CookC. Accuracy of glycemic measurements in the critically ill. Diabetes Technol Ther.2008;10 (3): 169–77.
21.
CritchellCDSavareseVCallahanAAboudCJabbourSMarikP. Accuracy of bedside capillary blood glucose measurements in critically ill patients. Intensive Care Med.2007;33 (12): 2079–84.
22.
KlonoffDC. Benefits and limitations of self-monitoring of blood glucose. J Diabetes Sci Technol.2007;1 (1): 130–2.
23.
WoodWG. Problems and practical solutions in the external quality control of point of care devices with respect to the measurement of blood glucose. J Diabetes Sci Technol.2007;1 (2): 158–63.
24.
KoschinskyTJungheimKHeinemannL. Glucose sensors and the alternate site testing-like phenomenon: relationship between rapid blood glucose changes and glucose sensor signals. Diabetes Technol Ther.2003;5 (5): 829–42.
25.
DellwegSNosekLKapitzaCEssenpreisMBrandtDEssenpreisMKoschinskyTHeinemannL. Alternate site (like) phenomenon: rapid changes from hyporglycaemic to hyperglycaemic glucose levels in a clinical-experimental study in patients with type 1 diabetes. Poster 968, Diab Med 2006;(23 Issue s4);195.
26.
CarstensenBLindströmJSundvallJBorch-JohnsenKTuomilehtoJ, DPS Study Group. Measurement of blood glucose: comparison between different types of specimens. Ann Clin Biochem.2008;45 (Pt 2): 140–8.
27.
KremenJBláhaJMatiasMAnderlováKEllmererMPlankJPieberTSvanciaSHaluzíkM. Monitoring of glucose concentration in critical patients, comparing arterial blood glucose concentrations and interstitial glucose concentration measured by microdialysis technique. Vnitr Lek.2006;52 (9): 777–81.
28.
VoskanyanGKeenanDBMastrototaroJJSteilGM. Putative delays in interstitial fluid (ISF) glucose kinetics can be attributed to the glucose sensing systems used to measure them rather than the delay in ISF glucose itself. J Diabetes Sci Technol.2007;1 (5): 639–44.
29.
ChanAYSwaminathanRCockramCS. Effectiveness of sodium fluoride as a preservative of glucose in blood. Clin Chem.1989;35 (2): 315–7.
30.
MikeshLMBrunsDE. Stabilization of glucose in blood specimens: mechanism of delay in fluoride inhibition of glycolysis. Clin Chem.2008;54 (5): 930–2.
31.
ShiRBowenRFaixJD. Comparison of glucose concentration in paired heparinized and sodium fluoride containing samples. Clin Chem.2008;54 (6 Suppl): A227–8.
32.
SelvinECrainiceanuCMBrancatiFLCoreshJ. Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med.2007;167 (14): 1545–51.
33.
NakazakiMFukushigeEKoriyamaNFukudomeMHashiguchiHAsoKYanoJIkedaYKatoKTeiC. Strongest correlation of HbA(1c) with 1-month-earlier glucose levels in type 2 diabetes. Diabetes Res Clin Pract.2004;63 (3): 171–7.
34.
AvignonARadauceanuAMonnierL. Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care.1997;20 (12): 1822–6.
35.
RosedianiMAzidahAKMafauzyM. Correlation between fasting plasma glucose, post prandial glucose and glycated haemoglobin and fructosamine. Med J Malaysia.2006;61 (1): 67–71.
36.
OzmenSCilTAtayAETuzcuAKBahceciM. A simple way to estimate mean plasma glucose and to identify type 2 diabetic subjects with poor glycaemic control when a standardized HbA1c assay is not available. Diabet Med.2006;23 (10): 1151–4.
37.
BonoraECalcaterraFLombardiSBonfanteNFormentiniGBonadonnaRCMuggeoM. Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control. Diabetes Care.2001;24 (12): 2023–9.
38.
SvendsenPALauritzenTSøegaardUNerupJ. Glycosylated haemoglobin and steady-state mean blood glucose concentration in type 1 (insulin-dependent) diabetes. Diabetologia.1982;23 (5): 403–5.
39.
MakrisKSpanouLRambaouni-AntoneliAKoniariKDrakopoulosIRizosDHaliassosA. Relationship between mean blood glucose and glycated haemoglobin in type 2 diabetic patients. Diabet Med.2008;25 (2): 174–8.
40.
HempeJMGomezRMcCarterRJJrChalewSA. High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control. J Diabetes Complications.2002;16 (5): 313–20.
41.
MurataGHHoffmanRMDuckworthWCWendelCSShahJH, Diabetes Outcomes in Veterans Study. Contributions of weekly mean blood glucose values to hemoglobin A1c in insulin-treated type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES). Am J Med Sci.2004;327 (6): 319–23.
42.
RohlfingCLWiedmeyerHMLittleRREnglandJDTennillAGoldsteinDE. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care.2002;25 (2): 275–8.
43.
KilpatrickESRigbyASAtkinSL. Variability in the relationship between mean plasma glucose and HbA1c: implications for the assessment of glycemic control. Clin Chem.2007;53 (5): 897–901.
44.
Diabetes Research In Children Network (DirecNet) Study GroupBuckinghamBAKollmanCBeckRKalajianAFiallo-ScharerRTanseyMJFoxLAWilsonDMWeinzimerSARuedyKJTamborlaneWV. Evaluation of factors affecting CGMS calibration. Diabetes Technol Ther.2006;8 (3): 318–25.
PallayovaMDonicovaVDonicV. Possible cause of glucose oxidase-based sensor failure during clinical use of continuous glucose monitoring system. Diabetologia.2005;48 (Suppl 1): A301.
47.
Djakouré-PlatonoffCRadermerckerRReachGSlamaGSelamJI. Accuracy of the continuous glucose monitoring system in inpatient and outpatient conditions. Diabetes Metab.2003;29 (2 Pt 1): 159–62.
48.
ClarkeWLAndersonSFarhyLBretonMGonder-FrederickLCoxDKovatchevB. Evaluating the clinical accuracy of two continuous glucose sensors using continuous glucose-error grid analysis. Diabetes Care.2005;28 (10): 2412–7.
49.
BolandEMonsodTDeluciaMBrandtCAFernandoSTamborlaneWV. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care.2001;24 (11): 1858–62.
50.
Fiallo-ScharerR, Diabetes Research in Children Network Study Group. Eight-point glucose testing versus the continuous glucose monitoring system in evaluation of glycemic control in type 1 diabetes. J Clin Endocrinol Metab.2005;90 (6): 3387–91.
51.
HeptullaRAAllenHFGrossTMReiterEO. Continuous glucose monitoring in children with type 1 diabetes: before and after insulin pump therapy. Pediatr Diabetes.2004;5 (1): 10–5.
52.
MillerMStrangeP. Use of Fourier models for analysis and interpretation of continuous glucose monitoring glucose profiles. J Diabetes Sci Technol.2007;1 (5): 630–8.
53.
GargSJovanovicL. Relationship of fasting and hourly blood glucose levels to HbA1c values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor. Diabetes Care.2006;29 (12): 2644–9.
54.
ZavalkoffSRPolychronakosC. Evaluation of conventional blood glucose monitoring as an indicator of integrated glucose values using a continuous subcutaneous sensor. Diabetes Care.2002;25 (9): 1603–6.
55.
ChettyVTAlmullaAOdueyungboAThabaneL. The effect of continuous subcutaneous glucose monitoring (CGMS) versus intermittent whole blood finger-stick glucose monitoring (SBGM) on hemoglobin A1c (HBA1c) levels in type I diabetic patients: a systematic review. Diabetes Res Clin Pract.2008;81 (1): 79–87.
56.
UlfSRagnarHArneWPJohnnyL. Do high blood glucose peaks contribute to higher HbA1c? Results from repeated continuous glucose measurements in children. World J Pediatr.2008;4 (3): 215–21.
57.
SharpSRainbowS. Continuous glucose monitoring and haemoglobin A1c. Ann Clin Biochem.2002;39 (Pt 5): 516–7.
58.
SalardiSZucchiniSSantoniRRagniLGualandiSCicognaniAlCacciariE. The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA(1c) in pediatric type 1 diabetic patients. Diabetes Care.2002;25 (10): 1840–4.
59.
NathanDMTurgeonHReganS. Relationship between glycated haemoglobin levels and mean glucose levels over time. Diabetologia.2007;50 (11): 2239–44.
60.
NathanDMKuenenJBorgRZhengHSchoenfeldDHeineRJ, A1c-Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care.2008;31 (8): 1473–8.
61.
Diabetes Research in Children Network (DirecNet) Study Group, WilsonDMKollmanCXingDFiallo-ScharerRWeinzimerSSteffesMWysockiTBeckRRuedyKTamborlaneW. Relationship of A1C to glucose concentrations in children with type 1 diabetes: assessments by high-frequency glucose determinations by sensors. Diabetes Care.2008;31 (3): 381–5.
62.
KahnRFonsecaV. Translating the A1C assay. Diabetes Care.2008;31 (8): 1704–7.
63.
IqbalNMorganCMaksoudHIdrisI. Improving patients' knowledge on the relationship between HbA1c and mean plasma glucose improves glycaemic control among persons with poorly controlled diabetes. Ann Clin Biochem.2008;45 (Pt 5): 504–7.
64.
SaudekCDHermanWHSacksDBBergenstalRMEdelmanDDavidsonMB. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab.2008;93 (7): 2447–53.
